These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 18625429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S, Sanyal AJ.
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [Abstract] [Full Text] [Related]

  • 5. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A, Loria P, Adinolfi LE, Andreana A, Ruggiero G, Carulli N.
    Ann Ital Med Int; 2005 Nov; 20(1):10-22. PubMed ID: 15859390
    [Abstract] [Full Text] [Related]

  • 6. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L.
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection.
    Puri P, Sanyal AJ.
    Clin Liver Dis; 2006 Nov; 10(4):793-819. PubMed ID: 17164118
    [Abstract] [Full Text] [Related]

  • 11. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    Sanyal AJ.
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM, McCullough AJ.
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C and steatosis.
    Monto A.
    Semin Gastrointest Dis; 2002 Jan; 13(1):40-6. PubMed ID: 11944633
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C and steatosis.
    Dev A, Patel K, McHutchison JG.
    Clin Liver Dis; 2004 Nov; 8(4):881-92, ix. PubMed ID: 15464660
    [Abstract] [Full Text] [Related]

  • 16. Nonalcoholic fatty liver disease.
    Adams LA, Lindor KD.
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 19. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M.
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.